Viewing StudyNCT00215345



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00215345
Status: UNKNOWN
Last Update Posted: 2005-09-22
First Post: 2005-09-20

Brief Title: A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Sponsor: Department of Veterans Affairs New Jersey
Organization: Department of Veterans Affairs New Jersey

Organization Data

Organization: Department of Veterans Affairs New Jersey
Class: FED
Study ID: COXAON-0509-047
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Department of Veterans Affairs New Jersey
Lead Sponsor Class: FED
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Sanofi INDUSTRY
Pfizer INDUSTRY